Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bacterial Infections and Mycoses

  Free Subscription

Articles published in Transplantation

Retrieve available abstracts of 14 articles:
HTML format
Text format

Single Articles

    July 2018
  1. HAIDAR G, Singh N
    How we approach combination antifungal therapy for invasive aspergillosis and mucormycosis in transplant recipients.
    Transplantation. 2018 Jul 2. doi: 10.1097/TP.0000000000002353.
    PubMed     Text format     Abstract available

    June 2018
  2. NATORI Y, Ferreira VH, Nellimarla S, Husain S, et al
    Incidence, Outcomes, and Long-Term Immune Response to Tuberculosis in Organ Transplant Recipients.
    Transplantation. 2018 Jun 26. doi: 10.1097/TP.0000000000002340.
    PubMed     Text format     Abstract available

    February 2018
  3. SANTORO-LOPES G, Subramanian AK, Molina I, Aguado JM, et al
    Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors.
    Transplantation. 2018;102.
    PubMed     Text format    

    January 2018
  4. MONTGOMERY RA, Lonze BE, Tatapudi VS
    IgG Degrading Enzyme of Streptococcus Pyogenes: An Exciting New Development in Desensitization Therapy.
    Transplantation. 2018;102:2-4.
    PubMed     Text format    

    December 2017
  5. WEIGT SS, Wang X, Palchevskiy V, Patel N, et al
    Gene Expression Profiling of Bronchoalveolar Lavage Cells during Aspergillus Colonization of the Lung Allograft.
    Transplantation. 2017 Dec 18. doi: 10.1097/TP.0000000000002058.
    PubMed     Text format     Abstract available

    July 2017
  6. LEHINGUE S, Rambaud R, Guervilly C, Adda M, et al
    Fatal Septic Shock Triggered by Donor Transmitted Varicella Zoster Virus Reinfection 3 Days After Lung Transplantation.
    Transplantation. 2017 Jul 27. doi: 10.1097/TP.0000000000001899.
    PubMed     Text format    

    April 2017
  7. NEUBERGER JM, Bechstein WO, Kuypers DR, Burra P, et al
    Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.
    Transplantation. 2017;101.
    PubMed     Text format     Abstract available

    December 2016
  8. FREIRE MP, Oshiro IC, Pierrotti LC, Bonazzi PR, et al
    Carbapenem-Resistant Enterobacteriaceae Acquired before Liver Transplantation: Impact on Recipient Outcomes.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001620.
    PubMed     Text format     Abstract available

    July 2016
  9. SIMKINS J, Abbo LM, Camargo JF, Rosa R, et al
    Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
    Transplantation. 2016.
    PubMed     Text format     Abstract available

    June 2016
  10. MUNOZ L, Santin M
    Prevention and Management of Tuberculosis in Transplant Recipients: From Guidelines to Clinical Practice.
    Transplantation. 2016.
    PubMed     Text format     Abstract available

    March 2016
  11. SCHULZ U, Solidoro P, Muller V, Szabo A, et al
    CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients.
    Transplantation. 2016;100 Suppl 3:S5-S10.
    PubMed     Text format     Abstract available

  12. REA F, Potena L, Yonan N, Wagner F, et al
    Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation.
    Transplantation. 2016;100 Suppl 3:S19-26.
    PubMed     Text format     Abstract available

    The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV.
    Transplantation. 2016;100 Suppl 3:S11-8.
    PubMed     Text format     Abstract available

  14. GROSSI P, Mohacsi P, Szabolcs Z, Potena L, et al
    Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview.
    Transplantation. 2016;100 Suppl 3:S1-4.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.